Profil
Ian David Brown currently works at Yallingup Ventures Pty Ltd., as Chief Executive Officer & Managing Director from 2011, Rex Ortho Pty Ltd, as Independent Chairman, Embracing Future Holdings Ltd., as Independent Non-Executive Director from 2021, and Cytomatrix Pty Ltd., as Director.
Mr. Brown also formerly worked at RepRegen Ltd., as Chief Executive Officer from 2009 to 2011, Avanti Capital, as Chief Executive Officer & Managing Director from 2007 to 2009, Avanti Capital Pty Ltd., as Chief Executive Officer & Managing Director from 2007 to 2009, Intergrain Pty Ltd., as Independent Chairman, Omniblend Innovation Pty Ltd., as Independent Chairman, CyGenics Ltd., as Chief Operating Officer & Executive Director from 2001 to 2007, Recce Pharmaceuticals Ltd., as Non-Executive Director, Activ Foundation, Inc., as Director, Western Australian Angel Investors, Inc., as Director, and Nohla Therapeutics, Inc., as Director.
Mr. Brown received his Masters Business Admin degree in 2007 from The University of Queensland and Masters Business Admin degree in 2007 from Melbourne Business School.
Postes actifs de Ian Brown
| Sociétés | Poste | Début |
|---|---|---|
| EMBRACING FUTURE HOLDINGS LIMITED | Directeur/Membre du Conseil | 14/06/2021 |
Yallingup Ventures Pty Ltd. | Directeur Général | 01/01/2011 |
Rex Ortho Pty Ltd
Rex Ortho Pty Ltd Medical SpecialtiesHealth Technology Manufactures and supplies orthopedic equipment | Président | - |
Cytomatrix Pty Ltd.
Cytomatrix Pty Ltd. Miscellaneous Commercial ServicesCommercial Services Researches and develops novel cell culture scaffolds and systems for clinical applications | Directeur/Membre du Conseil | - |
Anciens postes connus de Ian Brown
| Sociétés | Poste | Fin |
|---|---|---|
Intergrain Pty Ltd.
Intergrain Pty Ltd. Agricultural Commodities/MillingProcess Industries Provides crop breeding services | Président | 29/04/2023 |
| RECCE PHARMACEUTICALS LTD | Directeur/Membre du Conseil | 23/06/2016 |
RepRegen Ltd.
RepRegen Ltd. Medical/Nursing ServicesHealth Services Develops synthetic, biologically-active and tissue engineering products | Directeur Général | 01/01/2011 |
Avanti Capital
Avanti Capital Investment ManagersFinance Avanti Capital invests in both public and private companies located in the UK and US. The firm focuses on companies with strong management team with a proven track record, potential for material growth in the short to medium term and undervalued assets. They invest across a wide range of sectors such as leisure, consumer brands, retail, and specialist support services. They generally invest through a combination of debt and equity. | Directeur Général | 01/01/2009 |
Avanti Capital Pty Ltd.
Avanti Capital Pty Ltd. Miscellaneous Commercial ServicesCommercial Services Provides management consulting services | Directeur Général | 01/01/2009 |
Formation de Ian Brown
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 16 |
|---|---|
CyGenics Ltd.
CyGenics Ltd. Miscellaneous Commercial ServicesCommercial Services Operates a biotechnology company active in research | Commercial Services |
Melbourne Business School
Melbourne Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The University of Queensland
The University of Queensland Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
RepRegen Ltd.
RepRegen Ltd. Medical/Nursing ServicesHealth Services Develops synthetic, biologically-active and tissue engineering products | Health Services |
Avanti Capital
Avanti Capital Investment ManagersFinance Avanti Capital invests in both public and private companies located in the UK and US. The firm focuses on companies with strong management team with a proven track record, potential for material growth in the short to medium term and undervalued assets. They invest across a wide range of sectors such as leisure, consumer brands, retail, and specialist support services. They generally invest through a combination of debt and equity. | Finance |
Cytomatrix Pty Ltd.
Cytomatrix Pty Ltd. Miscellaneous Commercial ServicesCommercial Services Researches and develops novel cell culture scaffolds and systems for clinical applications | Commercial Services |
Intergrain Pty Ltd.
Intergrain Pty Ltd. Agricultural Commodities/MillingProcess Industries Provides crop breeding services | Process Industries |
Activ Foundation, Inc. | |
Avanti Capital Pty Ltd.
Avanti Capital Pty Ltd. Miscellaneous Commercial ServicesCommercial Services Provides management consulting services | Commercial Services |
Western Australian Angel Investors, Inc.
Western Australian Angel Investors, Inc. Financial ConglomeratesFinance Provides investment services | Finance |
Recce Pharmaceuticals Ltd.
Recce Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Creates and manufactures antibiotics | Health Technology |
Omniblend Innovation Pty Ltd.
Omniblend Innovation Pty Ltd. Pharmaceuticals: OtherHealth Technology Manufactures medical nutrition products | Health Technology |
Nohla Therapeutics, Inc.
Nohla Therapeutics, Inc. BiotechnologyHealth Technology Develops cellular therapies for hematological disorders | Health Technology |
Biolidics Ltd.
Biolidics Ltd. BiotechnologyHealth Technology Develops cell enrichment systems | Health Technology |
Rex Ortho Pty Ltd
Rex Ortho Pty Ltd Medical SpecialtiesHealth Technology Manufactures and supplies orthopedic equipment | Health Technology |
Yallingup Ventures Pty Ltd. |
















